Figure 1.

Discovery cohort: flowchart of patients included. *Death, lost to follow‐up, graft loss for another reason than rejection. **Not biopsy‐proven, protocol biopsy, borderline not treated, or pure humoral rejection. CNI, calcineurin inhibitor; MM, mismatch; PRA, panel reactive antibody; Tx, transplantation.